Anabel Sorolla
Anabel Sorolla
Miguel Servet Fellow at the IRBLleida
Verified email at
Cited by
Cited by
Distinction between active and passive targeting of nanoparticles dictate their overall therapeutic efficacy
TD Clemons, R Singh, A Sorolla, N Chaudhari, A Hubbard, KS Iyer
Langmuir 34 (50), 15343-15349, 2018
An ENU mutagenesis screen identifies novel and known genes involved in epigenetic processes in the mouse
L Daxinger, SK Harten, H Oey, T Epp, L Isbel, E Huang, N Whitelaw, ...
Genome biology 14 (9), 1-17, 2013
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
C Duffy, A Sorolla, E Wang, E Golden, E Woodward, K Davern, D Ho, ...
NPJ precision oncology 4 (1), 24, 2020
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells
D Llobet, N Eritja, M Encinas, A Sorolla, A Yeramian, JA Schoenenberger, ...
Anti-cancer drugs 19 (2), 115-124, 2008
Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system
B Garcia-Bloj, C Moses, A Sgro, J Plani-Lam, M Arooj, C Duffy, ...
Oncotarget 7 (37), 60535, 2016
CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells
D Llobet, N Eritja, M Encinas, N Llecha, A Yeramian, J Pallares, A Sorolla, ...
Oncogene 27 (18), 2513-2524, 2008
Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics
A Sorolla, E Wang, E Golden, C Duffy, ST Henriques, AD Redfern, ...
Oncogene 39 (6), 1167-1184, 2020
Functional expression of voltage‐gated calcium channels in human melanoma
A Das, C Pushparaj, N BahÝ, A Sorolla, J Herreros, R Pamplona, R Vilella, ...
Pigment cell & melanoma research 25 (2), 200-212, 2012
The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms
D Llobet, N Eritja, A Yeramian, J Pallares, A Sorolla, M Domingo, ...
European Journal of Cancer 46 (4), 836-850, 2010
Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
E Wang, A Sorolla, PT Cunningham, HM Bogdawa, S Beck, E Golden, ...
Oncogene 38 (1), 140-150, 2019
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway
A Yeramian, A Sorolla, A Velasco, M Santacana, X Dolcet, J Valls, L Abal, ...
International journal of cancer 130 (4), 967-978, 2012
Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma‐derived cell lines
A Sorolla, A Yeramian, X Dolcet, AM Perez de Santos, D Llobet, ...
British Journal of Dermatology 158 (3), 496-504, 2008
Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner
A Yeramian, M Santacana, A Sorolla, D Llobet, M Encinas, A Velasco, ...
Laboratory investigation 91 (6), 859-871, 2011
Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
A Sorolla, A Yeramian, J Valls, X Dolcet, L BergadÓ, A Llombart-Cussac, ...
Molecular oncology 6 (5), 530-541, 2012
From seabed to bedside: A review on promising marine anticancer compounds
E Wang, MA Sorolla, PD Gopal Krishnan, A Sorolla
Biomolecules 10 (2), 248, 2020
Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers
JA Kretzmann, CW Evans, C Moses, A Sorolla, AL Kretzmann, E Wang, ...
Chemical Science 10 (33), 7718-7727, 2019
Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides
A Sorolla, E Wang, TD Clemons, CW Evans, JHC Plani-Lam, E Golden, ...
Nanomedicine: Nanotechnology, Biology and Medicine 20, 102003, 2019
Loss of heterozygosity in endometrial carcinoma
A Velasco, J Pallares, M Santacana, A Yeramian, X Dolcet, N Eritja, ...
International journal of gynecological pathology 27 (3), 305-317, 2008
Crambescidin 800, Isolated from the Marine Sponge Monanchora viridis, Induces Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells
S Shrestha, A Sorolla, J Fromont, P Blancafort, GR Flematti
Marine drugs 16 (2), 53, 2018
Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide
BP Sorolla A, Ho D, Wang E, Evans CW, Ormonde CF, Rashwan R, Singh R, Iyer KS
Nanoscale 8 (17), 9343-53, 2016
The system can't perform the operation now. Try again later.
Articles 1–20